-
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Intent to Publish the Reissuance of RFA-AG-20-021, "Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Intent to Publish a Funding Opportunity Announcement for National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Change to Other Attachments in PAR-23-284 "Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2024, 2025, and 2026 (P50 Clinical Trial Required)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Availability of Frequently Asked Questions (FAQs) for PAR-23-289: Diagnostic Centers of Excellence for the Undiagnosed Diseases Network (U01 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of NIDCR Participation in RFA-NS-23-006, "HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Information Regarding NIGMS' Expanded Program Eligibility for PA-23-189 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Change to RFA-AI-23-055, Research Tools for Difficult to Culture Eukaryotic Pathogens (R61/R33 Clinical Trial Not Allowed) to Include Frequently Asked Questions Information
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Notice of Intent to Publish a Funding Opportunity Announcement for Centers of Excellence for Translational Research (CETR) (U19 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Change to section for PAR-23-194, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)"
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Human Islet Research Network - Consortium on Modeling Autoimmune Diabetes (HIRN-CMAD) (UG3/UH3 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Request for Information: Developing Consent Language for Research Using Digital Health Technologies
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Notice of Special Interest (NOSI): Advancing Genomic Medicine Research through Small Businesses
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Enhancing Biomedical Engineering, Imaging, and Technology Acceleration (BEITA) at Historically Black Colleges and Universities (HBCUs) (UG3/UH3 Clinical Trial Not Allowed)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Participation of NIMHD in PAR-23-292, Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
at National Institutes of Health in United States -
- Contract/Tender
- Posted 1 year ago
Notice of NHLBI Participation in NOT-MD-23-002 Notice of Special Interest (NOSI): Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations
at National Institutes of Health in United States -
- Contract/Tender
- Posted 1 year ago
Notice of Pre-Application Webinar for RFA-CA-23-039 and RFA-CA-23-040 for the National Cancer Institute "Human Tumor Atlas Network (HTAN)" Program
at National Institutes of Health in United States -
- Fellowship
- Posted 1 year ago
Notice of Intent to Publish a Funding Opportunity Announcement for Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Required)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Change to RFA-HD-24-010 "National Centers for Translational Research in Reproduction and Infertility (NCTRI) (P50 Clinical Trial Optional)"
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of Extension of the Expiration Date for PAR-21-115 Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of NICHD Participation in PAR-23-220, SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
at National Institutes of Health in United States -
- Research/Project Funding Opportunity
- Posted 1 year ago
Notice of NICHD Participation in PAR-23-219, SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
at National Institutes of Health in United States